Vir Biotechnology, Inc.

VIR Nasdaq CIK: 0001706431

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 1800 OWENS STREET, SAN FRANCISCO, CA, 94158
Mailing Address 1800 OWENS STREET, SAN FRANCISCO, CA, 94158
Phone 415-906-4324
Fiscal Year End 1231
EIN 812730369

Financial Overview

FY2024 FY

$1.62B
Revenue
-$521.96M
Net Income
$1.92B
Total Assets

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report February 3, 2026 View on SEC
8-K Current report of material events January 12, 2026 View on SEC
4 Insider stock transaction report January 5, 2026 View on SEC
8-K Current report of material events December 16, 2025 View on SEC
4 Insider stock transaction report December 3, 2025 View on SEC
4 Insider stock transaction report December 2, 2025 View on SEC
4 Insider stock transaction report December 1, 2025 View on SEC
4 Insider stock transaction report November 26, 2025 View on SEC
4 Insider stock transaction report November 18, 2025 View on SEC
4 Insider stock transaction report November 7, 2025 View on SEC

Insider Trading

STRONG SELL 2 insiders 8 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.